U.S. Drug Device Combination Products Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Transdermal Patches, Orthopedic Combination Products, Photodynamic Therapy Devices, Drug Eluting Stents) And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Product
                       1.2.2. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in Italy
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                   2.3. Competitive Insights
Chapter 3. Drug Device CombinationVariables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                       3.2.2. Market Restraint Analysis
                   3.3. U.S. Drug Device Combination Analysis Tools
                       3.3.1. Industry Analysis - Porter’s Five Forces
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. U.S. Drug Device Combination Products Market Product Estimates & Trend Analysis
                   4.1. U.S. Drug Device Combination Products Market Product Dashboard
                   4.2. U.S. Drug Device Combination Products Market Product Movement Analysis
                   4.3. U.S. Drug Device CombinationSize & Forecasts and Trend Analyses, 2018 to 2030
                   4.4. Infusion Pumps
                       4.4.1. Infusion pumps market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.4.2. Volumetric
                           4.4.2.1. Volumetric market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.4.3. Disposable
                           4.4.3.1. Disposable market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.4.4. Syringe
                           4.4.4.1. Syringe market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.4.5. Ambulatory
                           4.4.5.1. Ambulatory market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.4.6. Implantable
                           4.4.6.1. Implantable market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.4.7. Insulin
                           4.4.7.1. Insulin market estimates and forecasts, 2018 - 2030 (USD Billion)
                   4.5. Orthopedic Combination Products
                       4.5.1. Orthopedic combination products market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.5.2. Bone graft implants
                           4.5.2.1. Bone graft implants market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.5.3. Antibiotic bone cement
                           4.5.3.1. Antibiotic bone cement market estimates and forecasts, 2018 - 2030 (USD Billion)
                   4.6. Photodynamic Therapy Devices
                       4.6.1. Photodynamic therapy devices market estimates and forecasts, 2018 - 2030 (USD Billion)
                   4.7. Transdermal Patches
                       4.7.1. Transdermal patches market estimates and forecasts, 2018 - 2030 (USD Billion)
                   4.8. Drug Eluting Stents
                       4.8.1. Drug eluting stents market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.8.2. Coronary stents
                           4.8.2.1. Coronary stents market estimates and forecasts, 2018 - 2030 (USD Billion)
                           4.8.2.2. Peripheral vascular stents market estimates and forecasts, 2018 - 2030 (USD Billion).
                   4.9. Wound Care Products
                       4.9.1. Wound care products market estimates and forecasts, 2018 - 2030 (USD Billion)
                   4.10. Inhalers
                       4.10.1. Inhalers market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.10.2. Dry powder
                           4.10.2.1. Dry powder market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.10.3. Nebulizers
                           4.10.3.1. Nebulizers market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.10.4. Metered dose
                           4.10.4.1. Metered dose market estimates and forecasts, 2018 - 2030 (USD Billion)
                   4.11. Antimicrobial Catheters
                       4.11.1. Antimicrobial catheters market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.11.2. Urological
                           4.11.2.1. Urological market estimates and forecasts, 2018 - 2030 (USD Billion).
                       4.11.3. Cardiovascular
                           4.11.3.1. Cardiovascular market estimates and forecasts, 2018 - 2030 (USD Billion)
                       4.11.4. Others
                           4.11.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Billion)
                   4.12. Others
                       4.12.1. Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Competitive Landscape
                   5.1. Recent Developments & Impact Analysis, By Key Market Participants
                   5.2. Company/Competition Categorization
                   5.3. Vendor Landscape
                       5.3.1. List of key distributors and channel partners
                       5.3.2. Key customers
                       5.3.3. Key company market share analysis, 2023
                       5.3.4. Abbott
                           5.3.4.1. Flowonix Medical Company overview
                           5.3.4.2. Financial performance
                           5.3.4.3. Product benchmarking
                           5.3.4.4. Strategic initiatives
                       5.3.5. Eli Lilly
                           5.3.5.1. Company overview
                           5.3.5.2. Financial performance
                           5.3.5.3. Product benchmarking
                           5.3.5.4. Strategic initiatives
                       5.3.6. Terumo Medical Corporation
                           5.3.6.1. Company overview
                           5.3.6.2. Financial performance
                           5.3.6.3. Product benchmarking
                           5.3.6.4. Strategic initiatives
                       5.3.7. Stryker
                           5.3.7.1. Company overview
                           5.3.7.2. Financial performance
                           5.3.7.3. Product benchmarking
                           5.3.7.4. Strategic initiatives
                       5.3.8. Viatris, Inc
                           5.3.8.1. Company overview
                           5.3.8.2. Financial performance
                           5.3.8.3. Product benchmarking
                           5.3.8.4. Strategic initiatives
                       5.3.9. Boston Scientific Corporation
                           5.3.9.1. Company overview
                           5.3.9.2. Financial performance
                           5.3.9.3. Product benchmarking
                           5.3.9.4. Strategic initiatives
                       5.3.10. Becton, Dickinson and Company (BD)
                           5.3.10.1. Company overview
                           5.3.10.2. Financial performance
                           5.3.10.3. Product benchmarking
                           5.3.10.4. Strategic initiatives
                       5.3.11. Teleflex Incorporated
                           5.3.11.1. Company overview
                           5.3.11.2. Financial performance
                           5.3.11.3. Product benchmarking
                           5.3.11.4. Strategic initiatives
                       5.3.12. W. L. Gore & Associates, Inc
                           5.3.12.1. Company overview
                           5.3.12.2. Financial performance
                           5.3.12.3. Product benchmarking
                           5.3.12.4. Strategic initiatives
                       5.3.13. Mylan
                           5.3.13.1. Company overview
                           5.3.13.2. Financial performance
                           5.3.13.3. Product benchmarking
                           5.3.13.4. Strategic initiatives
                       5.3.14. Allergan
                           5.3.14.1. Company overview
                           5.3.14.2. Financial performance
                           5.3.14.3. Product benchmarking
                           5.3.14.4. Strategic initiatives
                       5.3.15. Cook Medical
                           5.3.15.1. Company overview
                           5.3.15.2. Financial performance
                           5.3.15.3. Product benchmarking
                           5.3.15.4. Strategic initiatives

List of Tables

TABLE 1 List of abbreviations
TABLE 2 U.S. Drug Device Combination Products Market, By Product, 2018 - 2030 (USD Billion)

List of Figures

FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Drug Device CombinationSegmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Drug Device Combination Products Market: Product outlook and key takeaways
FIG. 15 Drug Device Combination Products Market: Product Movement Analysis & Market Share 2023 & 2030
FIG. 16 Drug Device Combination infusion pumps market, 2018 - 2030 (USD Billion)
FIG. 17 Drug Device Combination volumetric market, 2018 - 2030 (USD Billion)
FIG. 18 Drug Device Combination disposable market, 2018 - 2030 (USD Billion)
FIG. 19 Drug Device Combination syringe market, 2018 - 2030 (USD Billion)
FIG. 20 Drug Device Combination ambulatory market, 2018 - 2030 (USD Billion)
FIG. 21 Drug Device Combination implantable market, 2018 - 2030 (USD Billion)
FIG. 22 Drug Device Combination insulin market, 2018 - 2030 (USD Billion)
FIG. 23 Drug Device Combination orthopedic combination products market, 2018 - 2030 (USD Billion)
FIG. 24 Drug Device Combination bone graft implants market, 2018 - 2030 (USD Billion)
FIG. 25 Drug Device Combination antibiotic bone cement market, 2018 - 2030 (USD Billion)
FIG. 26 Drug Device Combination photodynamic therapy devices market, 2018 - 2030 (USD Billion)
FIG. 27 Drug Device Combination transdermal patches market, 2018 - 2030 (USD Billion)
FIG. 28 Drug Device Combination drug eluting stents market, 2018 - 2030 (USD Billion)
FIG. 29 Drug Device Combination coronary stents market, 2018 - 2030 (USD Billion)
FIG. 30 Drug Device Combination peripheral vascular stents market, 2018 - 2030 (USD Billion)
FIG. 31 Drug Device Combination wound care products market, 2018 - 2030 (USD Billion)
FIG. 32 Drug Device Combination inhalers market, 2018 - 2030 (USD Billion)
FIG. 33 Drug Device Combination dry powder market, 2018 - 2030 (USD Billion)
FIG. 34 Drug Device Combination nebulizers market, 2018 - 2030 (USD Billion)
FIG. 35 Drug Device Combination metered dose market, 2018 - 2030 (USD Billion)
FIG. 36 Drug Device Combination antimicrobial catheters market, 2018 - 2030 (USD Billion)
FIG. 37 Drug Device Combination urological market, 2018 - 2030 (USD Billion)
FIG. 38 Drug Device Combination cardiovascular market, 2018 - 2030 (USD Billion)
FIG. 39 Drug Device Combination others market, 2018 - 2030 (USD Billion)
FIG. 40 Drug Device Combination others market, 2018 - 2030 (USD Billion)